Skip to main content

Table 1 Components of the site audit tool and response rates from 32 sites

From: A survey of tuberculosis infection control practices at the NIH/NIAID/DAIDS-supported clinical trial sites in low and middle income countries

Key components

Indicators

Details

Result

Facility level measures

Facility plan for implementation of TB infection control

Appointment of facility based IC officer

61.0 %

Policies and procedures (SOPs) for rapid identification, and isolation of TB cases

61.3 %

 

Optimized space

Waiting area ventilated and uncrowded

93.3 %

 

Annual surveillance of health care workers (HCWs) is conducted

Any or all of: Symptom screen/TB skin test/Interferon-gamma Release Assay (IGRA)/Chest x-ray

61.3 %

 

TB IC Policies monitored

1. Policies evaluated

80.6 %

2. Documentation of frequency of training, training materials updated

Administrative control measures

Identification and separation of patients with symptoms

1. Identification and separation of potentially infectious patients, including written procedures

71 %

2. Use of separate waiting rooms or outdoor waiting areas

Cough hygiene Education

1. Cough hygiene education signs

80.6 %

2. Resources for hand washing/disinfection

3. Masks for coughing patients and others with respiratory infection.

Hand hygiene Policy

1. Written policy or appropriate instructions for hand hygiene

67.7 %

2. Instructions posted

3. Availability and use of non-touch bins throughout the high-risk areas

 

Separation of sputum collection

Separate collection area

80.6 %

Well-ventilated area

Environmental control measures

Ventilation system is optimized

Air flow assessment performed

54.8 %

Ventilation and/or air cleaning

Windows open, use of other ventilation, air cleaning methods

80.6 %

 

Personal Protective Equipment (PPE) (PPE, N95 masks or equivalent, fit testing for masks)

PPE available

96.8 %

(N95 Masks), gloves and respirators

87.1 %

Fit Testing: written fit testing procedures, records for fit testing

43.3 %